In a hospital, a patient's journey is often a story told twice: once in the clinical record, and again in the administrative maze of insurance codes, quality reports, and trial enrollment forms. The second telling, a cross-system slog of repetitive data entry, is where human hours vanish and backlogs grow. Health Force, a Barcelona-based startup, is betting that the most practical way to reclaim those hours is not to build another dashboard, but to deploy AI agents that can log into the existing, creaky systems and do the work themselves [Health Force, retrieved 2026].
The Wedge: Work Done, Not Software Sold
Health Force's proposition is deliberately unglamorous. Instead of selling new software that requires lengthy integrations and staff retraining, its AI agents are designed to operate within a hospital's current digital environment. They authenticate into legacy systems, navigate between tabs, and execute defined workflows for tasks like processing insurance claims or compiling mandatory quality reports [Health Force, retrieved 2026]. Every action is logged and traceable, operating under human supervision where agents escalate only cases requiring complex judgment [Health Force, retrieved 2026]. The company's positioning is a direct rebuttal to analytics-heavy health tech: it sells "work done," measured in cleared backlogs and processed cases. Early reported results from Italian deployments include clearing a four-month case backlog within three weeks and automating 75% of insurance claims without human staff [Petra Pavlovic - Orbem | LinkedIn, retrieved 2026] [Health Force, retrieved 2026].
Traction in a Regulated Gateway
The company's initial beachhead is Italy, a strategic choice for testing in a complex, regulated European market. Through a partnership with Deloitte, Health Force secured its first hospital clients, including the prominent Humanitas Research Hospital and Ospedale Galeazzi of Gruppo San Donato [Konsulteer, retrieved 2026]. Its agents are now in daily production at these sites, and the company reports it processes over 200,000 patient cases annually across its Italian client base [Madjid Salimi - Co-Founder & Co-CEO of AMBOSS, retrieved 2026]. This early traction, validated in leading institutions, formed the core of the pitch for a €4.2 million seed round closed in September 2026 [HT World, September 2026]. The round was led by LUMO Labs, with participation from Step Venture, Next Tier Ventures, Target Global, and Calm/Storm Ventures [EU-Startups, September 2026]. The capital is earmarked for expanding the catalog of agent workflows and entering new European markets, including Germany, France, and Spain [TLD Rocket, September 2026].
The founding team brings a deliberate blend of clinical and technical credibility to the daunting task of automating hospital operations.
| Founder | Role | Key Background |
|---|---|---|
| Fadi Haddad | Co-founder, CEO | MD and Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center [Fadi Haddad |
| Juan Sebastián Suárez Valencia | Co-founder, Chief AI Officer | Physician and data engineer; former Chief Data Officer at Teladoc France [TLD Rocket, September 2026]. |
The Scale and Scrutiny Ahead
For all its reported early success, Health Force's path is lined with the rigorous scrutiny that defines digital health. The company's model depends on consistent, high-accuracy performance across thousands of transactions. A single mis-coded claim or erroneous data entry in a quality report could trigger financial penalties or compliance issues for a hospital client, eroding trust instantly. Furthermore, while the "no new software" wedge is a powerful sales tool, it may eventually bump against hospitals' own modernization roadmaps. As health systems gradually upgrade their core platforms, Health Force must ensure its agents remain compatible and valuable, rather than becoming a stopgap solution. The expansion into Germany and France will test the platform's ability to adapt to different national insurance formats, clinical coding standards, and regulatory reporting requirements, a challenge far greater than scaling within a single country.
Ultimately, Health Force is intervening in the disease state of administrative burden, a condition that afflicts healthcare systems globally and directly impacts patient access. The patient population here is not just the hospital administrator, but every person waiting for a prior authorization, a cleared bill, or a slot in a clinical trial. The standard of care today is largely manual: highly trained clinical and administrative staff spend hours each day as data-entry clerks, translating between clinical notes and billing systems, a process prone to delays, burnout, and error. If Health Force's agents can reliably shoulder that burden, the payoff isn't just efficiency, it's the reallocation of human attention back to where it matters most.
Sources
- [Health Force, retrieved 2026] Hire AI Agents for Hospital Operations | https://www.healthforce.ai/
- [HT World, September 2026] AI agent startup Health Force raises €4.2 million | https://htworld.co.uk/news/ai/ai-agent-startup-health-force-raises-e4-2-million-htai26/
- [EU-Startups, September 2026] Barcelona-based Health Force raises €4.2 million to streamline hospital operations with AI agents | https://www.eu-startups.com/2026/09/barcelona-based-health-force-raises-e4-2-million-to-streamline-hospital-operations-with-ai-agents/
- [TLD Rocket, September 2026] Health Force nets €4.2M to deploy its AI agents across Europe | https://tldrocket.com/story/health-force-nets-eur42m-to-deploy-its-ai-agents-across-europe
- [Petra Pavlovic - Orbem | LinkedIn, retrieved 2026] LinkedIn post on Health Force | https://at.linkedin.com/company/healthforceai
- [Madjid Salimi - Co-Founder & Co-CEO of AMBOSS, retrieved 2026] LinkedIn post on Health Force | https://at.linkedin.com/company/healthforceai
- [Konsulteer, retrieved 2026] Article on Health Force's Italian launch | https://www.healthforce.ai/
- [Fadi Haddad | UT MD Anderson, retrieved 2026] Faculty profile | https://www.mdanderson.org/research/departments-labs-institutes/departments-divisions/leukemia/fadi-haddad.html